Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Strategies for enhancing antibody delivery to the brain.

Frank RT, Aboody KS, Najbauer J.

Biochim Biophys Acta. 2011 Dec;1816(2):191-8. doi: 10.1016/j.bbcan.2011.07.002. Epub 2011 Jul 8. Review.

PMID:
21767610
2.

Getting into the brain: approaches to enhance brain drug delivery.

Patel MM, Goyal BR, Bhadada SV, Bhatt JS, Amin AF.

CNS Drugs. 2009;23(1):35-58. doi: 10.2165/0023210-200923010-00003. Review.

PMID:
19062774
4.

Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target.

Yu YJ, Zhang Y, Kenrick M, Hoyte K, Luk W, Lu Y, Atwal J, Elliott JM, Prabhu S, Watts RJ, Dennis MS.

Sci Transl Med. 2011 May 25;3(84):84ra44. doi: 10.1126/scitranslmed.3002230.

5.

Drug delivery to brain via the blood-brain barrier.

Scherrmann JM.

Vascul Pharmacol. 2002 Jun;38(6):349-54. Review.

PMID:
12529929
7.

Adsorptive-mediated brain delivery systems.

Lu W.

Curr Pharm Biotechnol. 2012 Sep;13(12):2340-8. Review.

PMID:
23016640
8.

A review of nanocarrier-based CNS delivery systems.

Tiwari SB, Amiji MM.

Curr Drug Deliv. 2006 Apr;3(2):219-32. Review.

PMID:
16611008
9.

Blood-brain barrier transport of non-viral gene and RNAi therapeutics.

Boado RJ.

Pharm Res. 2007 Sep;24(9):1772-87. Epub 2007 Jun 8. Review.

PMID:
17554608
10.

Current approaches for drug delivery to central nervous system.

Hossain S, Akaike T, Chowdhury EH.

Curr Drug Deliv. 2010 Dec;7(5):389-97. Review.

PMID:
20950269
11.

Drug targeting to the brain.

Pardridge WM.

Pharm Res. 2007 Sep;24(9):1733-44. Epub 2007 Jun 7. Review.

PMID:
17554607
13.

Nanostructures for drug delivery to the brain.

Martin-Banderas L, Holgado MA, Venero JL, Alvarez-Fuentes J, Fernández-Arévalo M.

Curr Med Chem. 2011;18(34):5303-21. Review.

PMID:
22087827
14.

Delivery of therapeutic peptides and proteins to the CNS.

Salameh TS, Banks WA.

Adv Pharmacol. 2014;71:277-99. doi: 10.1016/bs.apha.2014.06.004. Epub 2014 Aug 22. Review.

PMID:
25307220
15.

Molecular Trojan horses for blood-brain barrier drug delivery.

Pardridge WM.

Curr Opin Pharmacol. 2006 Oct;6(5):494-500. Epub 2006 Jul 12. Review.

PMID:
16839816
16.

Recent advances in medicinal chemistry and pharmaceutical technology--strategies for drug delivery to the brain.

Denora N, Trapani A, Laquintana V, Lopedota A, Trapani G.

Curr Top Med Chem. 2009;9(2):182-96. Review.

PMID:
19200004
17.

CNS drug delivery systems: novel approaches.

Pathan SA, Iqbal Z, Zaidi SM, Talegaonkar S, Vohra D, Jain GK, Azeem A, Jain N, Lalani JR, Khar RK, Ahmad FJ.

Recent Pat Drug Deliv Formul. 2009 Jan;3(1):71-89. Review.

PMID:
19149731
18.

Nanoparticulate systems for drug delivery and targeting to the central nervous system.

Craparo EF, Bondì ML, Pitarresi G, Cavallaro G.

CNS Neurosci Ther. 2011 Dec;17(6):670-7. doi: 10.1111/j.1755-5949.2010.00199.x. Epub 2010 Oct 15. Review.

PMID:
20950327
19.

Transport of a caspase inhibitor across the blood-brain barrier by chitosan nanoparticles.

Yemişci M, Gürsoy-Özdemir Y, Caban S, Bodur E, Capan Y, Dalkara T.

Methods Enzymol. 2012;508:253-69. doi: 10.1016/B978-0-12-391860-4.00013-6.

PMID:
22449930
20.

Nanotechnological advances for the delivery of CNS therapeutics.

Wong HL, Wu XY, Bendayan R.

Adv Drug Deliv Rev. 2012 May 15;64(7):686-700. doi: 10.1016/j.addr.2011.10.007. Epub 2011 Nov 7. Review.

PMID:
22100125
Items per page

Supplemental Content

Write to the Help Desk